RESUMO
Sickle cell trait (SCT), although generally a benign carrier state of hemoglobin S (HbAS), is a risk factor for exertional rhabdomyolysis (ERM), a rare but potentially fatal consequence of highly intense physical exercise, particularly among active-duty military personnel and high-performance athletes. The association between SCT and ERM is poorly understood. The objective of this study was to elucidate the genetic basis of ERM in an SCT-positive African American cohort. SCT-positive African Americans with a personal history of ERM (cases, n = 30) and without history of ERM (controls, n = 53) were enrolled in this study. Whole-genome sequencing was performed on DNA samples isolated from peripheral white blood cells. Participants' demographic, behavioral, and medical history information was obtained. An additional 131 controls were extracted from SCT-positive subjects of African descent from the 1000 Genomes Project. SCT carriers with ERM were characterized by myotoxicity features, significant muscle involvement dominated by muscle weakness, and severe pain and substantial increase in serum creatine kinase, with a mean value of 50,480 U/L. A distinctive feature of the SCT individuals with ERM was exertional collapse, which was reported in 53.3% of the cases in the study cohort. An important factor for the development of ERM was the duration and frequency of strenuous physical activity in the cases compared to the controls. Whole-genome sequencing identified 79,696 protein-coding variants. Genome-wide association analysis revealed that the p.C477R, rs115958260 variant in the SLC44A3 gene was significantly associated with ERM event in SCT-positive African Americans. The study results suggest that a combination of vigorous exercise and a genetic predisposing factor is involved in ERM.
Assuntos
Negro ou Afro-Americano , Estudo de Associação Genômica Ampla , Rabdomiólise , Traço Falciforme , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Negro ou Afro-Americano/genética , Exercício Físico , Militares , Rabdomiólise/genética , Traço Falciforme/genética , Sequenciamento Completo do Genoma , Proteínas Carreadoras de SolutosRESUMO
Long chain 3-hydroxyacyl-CoA dehydrogenase (LCHADD) is the only fatty acid oxidation disorder to develop a progressive chorioretinopathy resulting in vision loss; newborn screening (NBS) for this disorder began in the United States around 2004. We compared visual outcomes among 40 participants with LCHADD or trifunctional protein deficiency diagnosed symptomatically to those who were diagnosed via NBS or a family history. Participants completed ophthalmologic testing including measures of visual acuity, electroretinograms (ERG), fundal imaging, contrast sensitivity, and visual fields. Records were reviewed to document medical and treatment history. Twelve participants presented symptomatically with hypoglycemia, failure to thrive, liver dysfunction, cardiac arrest, or rhabdomyolysis. Twenty eight were diagnosed by NBS or due to a family history of LCHADD. Participants diagnosed symptomatically were older but had similar percent males and genotypes as those diagnosed by NBS. Treatment consisted of fasting avoidance, dietary long-chain fat restriction, MCT, C7, and/or carnitine supplementation. Visual acuity, rod- and cone-driven amplitudes on ERG, contrast sensitivity scores, and visual fields were all significantly worse among participants diagnosed symptomatically compared to NBS. In mixed-effects models, both age and presentation (symptomatic vs. NBS) were significant independent factors associated with visual outcomes. This suggests that visual outcomes were improved by NBS, but there was still lower visual function with advancing age in both groups. Early diagnosis and treatment by NBS is associated with improved visual outcomes and retinal function compared to participants who presented symptomatically. Despite the impact of early intervention, chorioretinopathy was greater with advancing age, highlighting the need for novel treatments.
Assuntos
Diagnóstico Precoce , Erros Inatos do Metabolismo Lipídico , Proteína Mitocondrial Trifuncional , Triagem Neonatal , Doenças Retinianas , Acuidade Visual , Humanos , Masculino , Feminino , Recém-Nascido , Erros Inatos do Metabolismo Lipídico/diagnóstico , Erros Inatos do Metabolismo Lipídico/genética , Erros Inatos do Metabolismo Lipídico/terapia , Criança , Doenças Retinianas/diagnóstico , Doenças Retinianas/genética , Proteína Mitocondrial Trifuncional/deficiência , Adulto , Lactente , Pré-Escolar , Adolescente , Doenças Musculares/diagnóstico , Doenças Musculares/genética , Adulto Jovem , Carnitina/análogos & derivados , Carnitina/uso terapêutico , Eletrorretinografia , Miopatias Mitocondriais/diagnóstico , Miopatias Mitocondriais/genética , 3-Hidroxiacil-CoA Desidrogenases/deficiência , 3-Hidroxiacil-CoA Desidrogenases/genética , Cardiomiopatias/diagnóstico , Cardiomiopatias/genética , Resultado do Tratamento , Rabdomiólise/diagnóstico , Rabdomiólise/genética , Doenças do Sistema NervosoRESUMO
PURPOSE: Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (LCHADD) is a rare fatty acid oxidation disorder characterized by recurrent episodes of metabolic decompensation and rhabdomyolysis, as well as retinopathy, peripheral neuropathy, and cardiac involvement, such as infantile dilated cardiomyopathy. Because LCHADD patients are surviving longer, we sought to characterize LCHADD-associated major cardiac involvement in adolescence and young adulthood. METHODS: A retrospective cohort of 16 adolescent and young adult participants with LCHADD was reviewed for cardiac phenotype. RESULTS: Major cardiac involvement occurred in 9 of 16 participants, including sudden death, out-of-hospital cardiac arrest, acute cardiac decompensations with heart failure and/or in-hospital cardiac arrest, end-stage dilated cardiomyopathy, and moderate restrictive cardiomyopathy. Sudden cardiac arrest was more common in males and those with a history of infant cardiomyopathy. CONCLUSION: The cardiac manifestations of LCHADD in adolescence and early adulthood are complex and distinct from the phenotype seen in infancy. Life-threatening arrhythmia occurs at substantial rates in LCHADD, often in the absence of metabolic decompensation or rhabdomyolysis. The potential risk factors identified here-male sex and history of infant cardiomyopathy-may hint at strategies for risk stratification and possibly the prevention of these events.
Assuntos
Erros Inatos do Metabolismo Lipídico , Fenótipo , Humanos , Masculino , Adolescente , Feminino , Adulto Jovem , Adulto , Erros Inatos do Metabolismo Lipídico/genética , Erros Inatos do Metabolismo Lipídico/patologia , Estudos Retrospectivos , Rabdomiólise/genética , Rabdomiólise/patologia , Rabdomiólise/enzimologia , 3-Hidroxiacil-CoA Desidrogenase de Cadeia Longa/genética , Cardiomiopatia Dilatada/genética , Cardiomiopatia Dilatada/patologia , Cardiomiopatias/genética , Cardiomiopatias/patologia , Morte Súbita Cardíaca/etiologia , Morte Súbita Cardíaca/patologiaRESUMO
INTRODUCTION/AIMS: Rhabdomyolysis is an etiologically heterogeneous, acute necrosis of myofibers characterized by transient marked creatine kinase (CK) elevation associated with myalgia, muscle edema, and/or weakness. The study aimed to determine the role of electrodiagnostic (EDX) testing relative to genetic testing and muscle biopsy in patients with unprovoked rhabdomyolysis in identifying an underlying myopathy. METHODS: EDX database was reviewed to identify unprovoked rhabdomyolysis patients who underwent EDX testing between January 2012 and January 2022. Each patient's clinical profile, EDX findings, muscle pathology, laboratory, and genetic testing results were analyzed. RESULTS: Of 66 patients identified, 32 had myopathic electromyography (EMG). Muscle biopsy and genetic testing were performed in 41 and 37 patients, respectively. A definitive diagnosis was achieved in 15 patients (11 myopathic EMG and 4 nonmyopathic EMG; p = .04) based on abnormal muscle biopsy (4/11 patients) or genetic testing (12/12 patients, encompassing 5 patients with normal muscle biopsy and 3 patients with nonmyopathic EMG). These included seven metabolic and eight nonmetabolic myopathies (five muscular dystrophies and three ryanodine receptor 1 [RYR1]-myopathies). Patients were more likely to have baseline weakness (p < .01), elevated baseline CK (p < .01), and nonmetabolic myopathies (p = .03) when myopathic EMG was identified. DISCUSSION: Myopathic EMG occurred in approximately half of patients with unprovoked rhabdomyolysis, more likely in patients with weakness and elevated CK at baseline. Although patients with myopathic EMG were more likely to have nonmetabolic myopathies, nonmyopathic EMG did not exclude myopathy, and genetic testing was primarily helpful to identify an underlying myopathy. Genetic testing should likely be first-tier diagnostic testing following unprovoked rhabdomyolysis.
Assuntos
Eletromiografia , Rabdomiólise , Humanos , Rabdomiólise/diagnóstico , Rabdomiólise/genética , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Músculo Esquelético/fisiopatologia , Músculo Esquelético/patologia , Idoso , Sequenciamento de Nucleotídeos em Larga Escala , Testes Genéticos/métodos , Eletrodiagnóstico/métodos , Adulto Jovem , Creatina Quinase/sangue , Biópsia , Estudos Retrospectivos , AdolescenteRESUMO
Major clinical events (MCEs) related to long-chain fatty acid oxidation disorders (LC-FAOD) in triheptanoin clinical trials include inpatient or emergency room (ER) visits for three major clinical manifestations: rhabdomyolysis, hypoglycemia, and cardiomyopathy. However, outcomes data outside of LC-FAOD clinical trials are limited. The non-interventional cohort LC-FAOD Odyssey study examines data derived from US medical records and patient reported outcomes to quantify LC-FAOD burden according to management strategy including MCE frequency and healthcare resource utilization (HRU). Thirty-four patients were analyzed of which 21 and 29 patients had received triheptanoin and/or medium chain triglycerides (MCT), respectively. 36% experienced MCEs while receiving triheptanoin versus 54% on MCT. Total mean annualized MCE rates on triheptanoin and MCT were 0.1 and 0.7, respectively. Annualized disease-related inpatient and ER events were lower on triheptanoin (0.2, 0.3, respectively) than MCT (1.2, 1.0, respectively). Patients were managed more in an outpatient setting on triheptanoin (8.9 annualized outpatient visits) vs MCT (7.9). Overall, this shows that those with LC-FAOD in the Odyssey program experienced fewer MCEs and less HRU in inpatient and ER settings during triheptanoin-treated periods compared with the MCT-treated periods. The MCE rate was lower after initiation of triheptanoin, consistent with clinical trials.
Assuntos
Ácidos Graxos , Erros Inatos do Metabolismo Lipídico , Triglicerídeos , Humanos , Masculino , Feminino , Estados Unidos , Erros Inatos do Metabolismo Lipídico/genética , Erros Inatos do Metabolismo Lipídico/tratamento farmacológico , Ácidos Graxos/metabolismo , Adolescente , Oxirredução , Criança , Adulto , Pré-Escolar , Rabdomiólise/genética , Rabdomiólise/tratamento farmacológico , Hipoglicemia , Cardiomiopatias/tratamento farmacológico , Cardiomiopatias/genética , Lactente , Adulto Jovem , Recursos em Saúde , Pessoa de Meia-IdadeRESUMO
ABSTRACT: Sickle cell trait is typically thought to be an asymptomatic carrier state, but it is rarely associated with exertional rhabdomyolysis in cases termed Exercise Collapse Associated with Sickle Cell Trait (ECAST). In a subset of these cases, underlying disease contributes to the development and/or severity of the ensuing medical complications. We describe the first ever case of ECAST reported in a previously asymptomatic, multiply deployed, highly physically active service member with an underlying heterozygous LAMA2 mutation. Moreover, the mutation identified via whole exome sequencing is a novel, likely pathogenic variant that has yet to be described in the literature.
Assuntos
Laminina , Mutação , Rabdomiólise , Traço Falciforme , Humanos , Traço Falciforme/genética , Traço Falciforme/complicações , Masculino , Laminina/genética , Rabdomiólise/genética , Rabdomiólise/etiologia , Exercício Físico , Militares , Adulto , Heterozigoto , Evolução Fatal , Sequenciamento do ExomaRESUMO
Acute rhabdomyolysis (AR) leading to acute kidney injury has many underlying etiologies, however, when the primary trigger is exercise, the most usual underlying cause is either a genetic muscle disorder or unaccustomed intense exercise in a healthy individual. Three adult men presented with a history of exercise intolerance and episodes of acute renal impairment following intense exercise, thought to be due to AR in the case of two, and dehydration in one. The baseline serum CK was mildly raised between attacks in all three patients and acutely raised during attacks in two of the three patients. Following referral to a specialized neuromuscular centre, further investigation identified very low serum urate (<12 umol/L). In all three men, genetic studies confirmed homozygous mutations in SLC2A9, which encodes for facilitated glucose transporter member 9 (GLUT9), a major regulator of urate homeostasis. Hereditary hypouricaemia should be considered in people presenting with acute kidney injury related to intense exercise. Serum urate evaluation is a useful screening test best undertaken after recovery.
Assuntos
Injúria Renal Aguda , Erros Inatos do Transporte Tubular Renal , Rabdomiólise , Cálculos Urinários , Masculino , Adulto , Humanos , Ácido Úrico , Cálculos Urinários/genética , Cálculos Urinários/complicações , Cálculos Urinários/diagnóstico , Erros Inatos do Transporte Tubular Renal/genética , Erros Inatos do Transporte Tubular Renal/complicações , Erros Inatos do Transporte Tubular Renal/diagnóstico , Proteínas Facilitadoras de Transporte de Glucose/genética , Injúria Renal Aguda/genética , Mutação , Rabdomiólise/genética , Rabdomiólise/complicaçõesRESUMO
Obscurin, encoded by the OBSCN gene, is a muscle protein consisting of three main splice isoforms, obscurin-A, obscurin-B, and obscurin kinase-only protein (also known as KIAA1639 or Obsc-kin). Obscurin is located at the M-band and Z-disks and interacts with titin and myomesin. It plays an important role in the stability and maintenance of the A- and M-bands and the subsarcolemmal organization of the microtubule network. Furthermore, obscurin is involved in Ca2+ regulation and sarcoplasmic reticulum function and is connected to several other muscle proteins. OBSCN gene variants have been reported to be relatively common in inherited cardiomyopathies. Here we reported two young patients with a history of cramps, myalgia, exercise intolerance, rhabdomyolysis, and myoglobinuria without any evidence of concomitant cardiomyopathy in association with novel OBSCN variants (c.24822C>A and c.2653+1G>C). Obscurin-deficient muscle fibers seem to have increased susceptibility to damage triggered by exercise that may lead to rhabdomyolysis. More studies are needed to clarify the diverse clinical phenotypes and the pathophysiology of OBSCN gene variants.
Assuntos
Proteínas Musculares , Rabdomiólise , Humanos , Proteínas Musculares/genética , Proteínas Musculares/metabolismo , Fibras Musculares Esqueléticas/metabolismo , Sarcômeros , Retículo Sarcoplasmático/metabolismo , Rabdomiólise/genética , Rabdomiólise/metabolismo , Proteínas Serina-Treonina Quinases/genética , Fatores de Troca de Nucleotídeo Guanina Rho/genética , Fatores de Troca de Nucleotídeo Guanina Rho/metabolismoRESUMO
Rabdomiólise é uma síndrome que leva a lesão da célula musculoesquelética com liberação dos componentes celulares para a corrente sanguínea. Tem como um dos principais causadores a atividade muscular exaustiva e extenuante, especialmente em indivíduos não condicionados. A lista de etiologias é constantemente expandida à medida que se aprofundam os estudos sobre o tema. Essa pesquisa teve como objetivo analisar as consequências, causas e processos potencializadores de rabdomiólise em militares, com implicações na Saúde Pública. Como percurso metodológico utilizou-se a revisão integrativa, pois esta permite explorar o conhecimento científico já produzido, através de etapas metodológicas que possibilitam buscar, avaliar e sintetizar as evidências, contribuindo com o desenvolvimento do conhecimento. Foram selecionados 25 estudos nas bases de dados Pubmed, Lilacs, Scopus, Cochrane e Scielo, que demonstraram uma tendência para atividade física extenuante como a principal causa da rabdomiólise em 76,5 por cento das amostras, destacaram-se como potencializadores as alterações genéticas e calor, ambas como 41,6 por cento e como principal consequência a insuficiência renal aguda com 84,6 por cento. Concluiu-se que o conhecimento ainda insatisfatório apresentado sobre esta síndrome merece atenção, visto que, a rabdomiólise é majoritariamente conhecida em meio militar. Assim, a conscientização sobre a necessidade de futuros estudos é necessária para a expansão e divulgação do conhecimento acerca da rabdomiólise, facilitando assim, o monitoramento e prevenção de riscos em decorrência do esforço muscular intenso em outras categorias de trabalhadores sujeitas a atividades laborais similares às atividades militares, tornando-se, assim, um importante fator para o desenvolvimento da saúde pública.
Rhabdomyolysis is a syndrome that leads to skeletal muscle cell injury with liberation of cell components to the blood. One of its major causes is exhaustive and extenuating physical activities, especially in non-conditioned individuals. Several conditions and diseases may lead to rhabdomyolysis and its list of causes is constantly being updated. This researchs goals is to analyze the consequences, causes and intensifying factors of rhabdomyolysis in military personnel, with Public Health implications. The methodology used for this research was the integrative revision, which allows exploring of the current scientific knowledge, through searching, evaluating and synthetizing of the evidences, contributing to the development of the knowledge. Twenty-five studies were selected in the Pubmed, Lilacs, Scopus, Cochrane and Scielo databases, which showed a tendency of extenuating physical activity as the main cause of rhabdomyolysis in 76,5 percent of the cases, the heat and genetic changes as worsening factor both in 41,6 percent, and the main consequence of acute renal insufficiency in 84,6 percent. It was concluded that the still unsatisfactory knowledge of this syndrome deserves attention, as rhabdomyolysis is mainly known in the Armed Forced. This shows that the need of future studies about rhabdomyolysis would facilitate the monitoring and prevention of risks due to intense muscular activity in other classes of workers subjected to similar working activities to those of military personnel, becoming an important factor to the development of public health.